skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 246  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Identification of RET fusions in a Chinese multicancer retrospective analysis by next‐generation sequencing
Material Type:
Article
Add to My Research

Identification of RET fusions in a Chinese multicancer retrospective analysis by next‐generation sequencing

Cancer science, 2022-01, Vol.113 (1), p.308-318 [Peer Reviewed Journal]

2021 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2021 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15181 ;PMID: 34710947

Full text available

2
Osimertinib in Japanese patients with EGFR T790M mutation‐positive advanced non‐small‐cell lung cancer: AURA3 trial
Material Type:
Article
Add to My Research

Osimertinib in Japanese patients with EGFR T790M mutation‐positive advanced non‐small‐cell lung cancer: AURA3 trial

Cancer science, 2018-06, Vol.109 (6), p.1930-1938 [Peer Reviewed Journal]

2018 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.13623 ;PMID: 29697876

Full text available

3
Analysis of the upstream genetic structures of the ISEcp1-bla CTX-M transposition units in Escherichia coli isolates carrying bla CTX-M obtained from the Indonesian and Vietnamese communities
Material Type:
Article
Add to My Research

Analysis of the upstream genetic structures of the ISEcp1-bla CTX-M transposition units in Escherichia coli isolates carrying bla CTX-M obtained from the Indonesian and Vietnamese communities

Microbiology and immunology, 2021-12, Vol.65 (12), p.542 [Peer Reviewed Journal]

2021 The Societies and John Wiley & Sons Australia, Ltd. ;EISSN: 1348-0421 ;PMID: 34581451

Full text available

4
Osimertinib in patients with epidermal growth factor receptor T790M advanced non‐small cell lung cancer selected using cytology samples
Material Type:
Article
Add to My Research

Osimertinib in patients with epidermal growth factor receptor T790M advanced non‐small cell lung cancer selected using cytology samples

Cancer science, 2018-04, Vol.109 (4), p.1177-1184 [Peer Reviewed Journal]

2018 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2018. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.13511 ;PMID: 29363250

Full text available

5
Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinoma
Material Type:
Article
Add to My Research

Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinoma

Cancer science, 2021-01, Vol.112 (1), p.305-313 [Peer Reviewed Journal]

2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2021. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.14681 ;PMID: 33047430

Full text available

6
Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI‐1 study
Material Type:
Article
Add to My Research

Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI‐1 study

Cancer science, 2020-02, Vol.111 (2), p.513-527 [Peer Reviewed Journal]

2019 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2019 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2020. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.14264 ;PMID: 31789476

Full text available

7
Internet overuse and excessive daytime sleepiness in adolescents
Material Type:
Article
Add to My Research

Internet overuse and excessive daytime sleepiness in adolescents

Psychiatry and clinical neurosciences, 2009-08, Vol.63 (4), p.455-462 [Peer Reviewed Journal]

2009 The Authors. Journal compilation © 2009 Japanese Society of Psychiatry and Neurology ;2009 INIST-CNRS ;ISSN: 1323-1316 ;EISSN: 1440-1819 ;DOI: 10.1111/j.1440-1819.2009.01925.x ;PMID: 19490510

Full text available

8
Molecular pathology quality control in Southeast Asia: Results of a multiregional quality assurance study from MASTER KEY Asia
Material Type:
Article
Add to My Research

Molecular pathology quality control in Southeast Asia: Results of a multiregional quality assurance study from MASTER KEY Asia

Cancer science, 2023-06, Vol.114 (6), p.2664-2673 [Peer Reviewed Journal]

2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15790 ;PMID: 36919757

Full text available

9
Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium
Material Type:
Article
Add to My Research

Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium

Cancer science, 2018-02, Vol.109 (2), p.435-445 [Peer Reviewed Journal]

2017 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2017 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.13470 ;PMID: 29247577

Full text available

10
Gene aberrations for precision medicine against lung adenocarcinoma
Material Type:
Article
Add to My Research

Gene aberrations for precision medicine against lung adenocarcinoma

Cancer science, 2016-06, Vol.107 (6), p.713-720 [Peer Reviewed Journal]

2016 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2016. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.12941 ;PMID: 27027665

Full text available

11
Phase I study of the irreversible fibroblast growth factor receptor 1–4 inhibitor futibatinib in Japanese patients with advanced solid tumors
Material Type:
Article
Add to My Research

Phase I study of the irreversible fibroblast growth factor receptor 1–4 inhibitor futibatinib in Japanese patients with advanced solid tumors

Cancer science, 2023-02, Vol.114 (2), p.574-585 [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15486 ;PMID: 35838190

Full text available

12
Mitochondrial DNA haplogroup M7: A predictor of poor prognosis for colorectal cancer patients in Chinese population
Material Type:
Article
Add to My Research

Mitochondrial DNA haplogroup M7: A predictor of poor prognosis for colorectal cancer patients in Chinese population

Cancer science, 2023-03, Vol.114 (3), p.1056-1066 [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15654 ;PMID: 36382493

Full text available

13
Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs
Material Type:
Article
Add to My Research

Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs

Cancer science, 2022-07, Vol.113 (7), p.2224-2231 [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15377 ;PMID: 35445479

Full text available

14
Phase I, multicenter, open‐label, dose‐escalation study of sonidegib in Asian patients with advanced solid tumors
Material Type:
Article
Add to My Research

Phase I, multicenter, open‐label, dose‐escalation study of sonidegib in Asian patients with advanced solid tumors

Cancer science, 2016-10, Vol.107 (10), p.1477-1483 [Peer Reviewed Journal]

2016 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2016. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.13022 ;PMID: 27467121

Full text available

15
Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose
Material Type:
Article
Add to My Research

Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose

Cancer science, 2015-05, Vol.106 (5), p.497-504 [Peer Reviewed Journal]

2015 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd on behalf of Japanese Cancer Association. ;2015. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd on behalf of Japanese Cancer Association. 2015 ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.12647 ;PMID: 25728850

Full text available

16
Seven‐plus hours of daily sedentary time and the subsequent risk of breast cancer: Japan Multi‐Institutional Collaborative Cohort Study
Material Type:
Article
Add to My Research

Seven‐plus hours of daily sedentary time and the subsequent risk of breast cancer: Japan Multi‐Institutional Collaborative Cohort Study

Cancer science, 2024-02, Vol.115 (2), p.611-622 [Peer Reviewed Journal]

2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.16020 ;PMID: 38041484

Full text available

17
Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE‐1 (phase 2) Japanese cohort
Material Type:
Article
Add to My Research

Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE‐1 (phase 2) Japanese cohort

Cancer science, 2022-12, Vol.113 (12), p.4267-4276 [Peer Reviewed Journal]

2022 Janssen Research and Development, LLC. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 Janssen Research and Development, LLC. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15556 ;PMID: 36052883

Full text available

18
Phase 1 trial of zolbetuximab in Japanese patients with CLDN18.2+ gastric or gastroesophageal junction adenocarcinoma
Material Type:
Article
Add to My Research

Phase 1 trial of zolbetuximab in Japanese patients with CLDN18.2+ gastric or gastroesophageal junction adenocarcinoma

Cancer science, 2023-04, Vol.114 (4), p.1606-1615 [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15684 ;PMID: 36478334

Full text available

19
Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non‐small‐cell lung cancer in KEYNOTE‐407
Material Type:
Article
Add to My Research

Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non‐small‐cell lung cancer in KEYNOTE‐407

Cancer science, 2023-08, Vol.114 (8), p.3330-3341 [Peer Reviewed Journal]

2023 Merck Sharp & Dohme LLC and The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023 Merck Sharp & Dohme LLC and The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15816 ;PMID: 37183528

Full text available

20
Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine‐refractory differentiated thyroid cancer
Material Type:
Article
Add to My Research

Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine‐refractory differentiated thyroid cancer

Cancer science, 2015-12, Vol.106 (12), p.1714-1721 [Peer Reviewed Journal]

2015 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd on behalf of Japanese Cancer Association. ;2015. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.12826 ;PMID: 26426092

Full text available

Results 1 - 20 of 246  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait